Understanding the neural correlates of cognitive problems in patients with breast cancer (BC) after systemic treatment have been a topic of increasing investigation. The heterogeneity of the systemic treatment regimens may undermine our ability to identify brain microstructural alterations resulting from any given regimen. We investigated the detrimental effects of the anthracycline-based systemic treatment (AST) regimen (epirubicin and cyclophosphamide + docetaxel + tamoxifen) on brain gray matter (GM) and white matter (WM) microstructural alteration in long-term BC survivors. We performed a battery of neuropsychological tests and structural magnetic resonance imaging (MRI) to 31 long-term BC survivors who had received the AST regimen (AST group) and 43 healthy controls (HC group). Voxel-based morphometry evaluated the whole-brain voxel-wise GM volume, while diffusion tensor imaging technique with tract‐based spatial statistics analysis evaluated whole-brain WM microstructural alteration. Partial least squares regression (PLSR) was used to evaluate the relationship between cognitive impairment and brain microstructural alteration in BC survivors. Compared with the HC group, the AST group exhibited a significantly poorer performance in attention, as well as a marginal significantly poorer performance in verbal working memory and executive function. Significantly lower fractional anisotropy (FA), higher radial diffusivity (RD), and lower axial diffusivity (AD) in multiple brain WM regions were showed in AST group compared with the HC group. Overlap of lower FA and higher RD was found in the body of corpus callosum (CC) and bilateral superior corona radiata (SCR), whereas overlap of lower FA and AD was found in the body of CC and right SCR. The PLSR results showed that the WM regions with overlap of lower FA and AD were significantly associated with executive and verbal working memory decline. No significant difference was observed in the GM volume between groups. Our results suggest that microstructural abnormalities of certain vulnerable WM regions in the AST regimen-exposed brain may provide neuroimaging evidence for the identification of brain injury and cognitive impairment induced by specific chemotherapy regimens.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012). Cancer- and cancer treatment-associated cognitive change: An update on the state of the science. Journal of Clinical Oncology, 30(30), 3675–3686. https://doi.org/10.1200/JCO.2012.43.0116
Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7(3), 192–201. https://doi.org/10.1038/nrc2073
Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., . . . Kaufman, P. A. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol, 28(29), 4434-4440. https://doi.org/10.1200/JCO.2009.27.0827
Alexander, A. L., Lee, J. E., Lazar, M., & Field, A. S. (2007). Diffusion tensor imaging of the brain. Neurotherapeutics, 4(3), 316–329. https://doi.org/10.1016/j.nurt.2007.05.011
Andica, C., Kamagata, K., Hatano, T., Saito, A., Uchida, W., Ogawa, T., . . . Aoki, S. (2019). Free-Water Imaging in White and Gray Matter in Parkinson's Disease. Cells, 8(8). https://doi.org/10.3390/cells8080839
Arbuthnott, K., & Frank, J. (2000). Trail making test, part B as a measure of executive control: Validation using a set-switching paradigm. Journal of Clinical and Experimental Neuropsychology, 22(4), 518–528. https://doi.org/10.1076/1380-3395(200008)22:4;1-0;FT518
Barton, M. K. (2013). Cognitive deficits are usually mild in patients with breast cancer after chemotherapy. CA: A Cancer Journal for Clinicians, 63(1), 3–4. https://doi.org/10.3322/caac.21164
Billiet, T., Emsell, L., Vandenbulcke, M., Peeters, R., Christiaens, D., Leemans, A., . . . Deprez, S. (2018). Recovery from chemotherapy-induced white matter changes in young breast cancer survivors? Brain Imaging Behav, 12(1), 64-77. https://doi.org/10.1007/s11682-016-9665-8
Bourisly, A. K., Gejo, G., Hayat, A. A., Alsarraf, L., Dashti, F. M., & Di Paola, M. (2017). White Matter Sexual Dimorphism of the Adult Human Brain. Translational Neuroscience, 8, 49–53. https://doi.org/10.1515/tnsci-2017-0009
Chen, B. T., Ye, N., Wong, C. W., Patel, S. K., Jin, T., Sun, C. L., . . . Dale, W. (2020). Effects of chemotherapy on aging white matter microstructure: A longitudinal diffusion tensor imaging study. J Geriatr Oncol, 11(2), 290-296. https://doi.org/10.1016/j.jgo.2019.09.016
Chen, H. L., Huang, C. C., Lin, H. C., Lu, C. H., Chen, P. C., Chou, K. H., . . . Lin, W. C. (2020). White matter alteration and autonomic impairment in obstructive sleep apnea. J Clin Sleep Med, 16(2), 293-302. https://doi.org/10.5664/jcsm.8186
Chen, X., Li, J., Zhang, J., He, X., Zhu, C., Zhang, L., . . . Wang, K. (2017). Impairment of the executive attention network in premenopausal women with hormone receptor-positive breast cancer treated with tamoxifen. Psychoneuroendocrinology, 75, 116-123. https://doi.org/10.1016/j.psyneuen.2016.10.020
Correa, D. D., Root, J. C., Kryza-Lacombe, M., Mehta, M., Karimi, S., Hensley, M. L., & Relkin, N. (2017). Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: A pilot study. Brain Imaging and Behavior, 11(6), 1652–1663. https://doi.org/10.1007/s11682-016-9608-4
de Blank, P. M., Berman, J. I., & Fisher, M. J. (2016). Systemic Chemotherapy and White Matter Integrity in Tracts Associated with Cognition Among Children With Neurofibromatosis Type 1. Pediatric Blood & Cancer, 63(5), 818–824. https://doi.org/10.1002/pbc.25896
de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., . . . Schagen, S. B. (2012). Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp, 33(12), 2971-2983. https://doi.org/10.1002/hbm.21422
Deprez, S., Amant, F., Smeets, A., Peeters, R., Leemans, A., Van Hecke, W., . . . Sunaert, S. (2012). Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol, 30(3), 274-281. https://doi.org/10.1200/JCO.2011.36.8571
Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., . . . Sunaert, S. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum Brain Mapp, 32(3), 480-493. https://doi.org/10.1002/hbm.21033
Dietrich, J., Han, R., Yang, Y., Mayer-Proschel, M., & Noble, M. (2006). CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. Journal of Biology, 5(7), 22. https://doi.org/10.1186/jbiol50
Feng, Y., Zhang, X. D., Zheng, G., & Zhang, L. J. (2019). Chemotherapy-induced brain changes in breast cancer survivors: evaluation with multimodality magnetic resonance imaging. Brain Imaging Behav, 13(6), 1799-1814. https://doi.org/10.1007/s11682-019-00074-y
Foubert-Samier, A., Catheline, G., Amieva, H., Dilharreguy, B., Helmer, C., Allard, M., & Dartigues, J. F. (2012). Education, occupation, leisure activities, and brain reserve: a population-based study. Neurobiol Aging, 33(2), 423 e415-425. https://doi.org/10.1016/j.neurobiolaging.2010.09.023
Ganz, P. A., Petersen, L., Castellon, S. A., Bower, J. E., Silverman, D. H., Cole, S. W., . . . Belin, T. R. (2014). Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study. J Clin Oncol, 32(31), 3559-3567. https://doi.org/10.1200/JCO.2014.56.1662
Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Proschel, M., & Noble, M. (2008). Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. Journal of Biology, 7(4), 12. https://doi.org/10.1186/jbiol69
Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., . . . Uchitomi, Y. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer, 109(1), 146-156. https://doi.org/10.1002/cncr.22368
Janelsins, M. C., Heckler, C. E., Peppone, L. J., Kamen, C., Mustian, K. M., Mohile, S. G., . . . Morrow, G. R. (2017). Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study. J Clin Oncol, 35(5), 506-514. https://doi.org/10.1200/JCO.2016.68.5826
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014). Prevalence, mechanisms, and management of cancer-related cognitive impairment. International Review of Psychiatry, 26(1), 102–113. https://doi.org/10.3109/09540261.2013.864260
Janelsins, M. C., Mustian, K. M., Palesh, O. G., Mohile, S. G., Peppone, L. J., Sprod, L. K., . . . Morrow, G. R. (2012). Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer, 20(4), 831-839. https://doi.org/10.1007/s00520-011-1158-0
Jim, H. S., Phillips, K. M., Chait, S., Faul, L. A., Popa, M. A., Lee, Y. H., . . . Small, B. J. (2012). Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol, 30(29), 3578-3587. https://doi.org/10.1200/JCO.2011.39.5640
Kesler, S. R., & Blayney, D. W. (2016). Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. JAMA Oncology, 2(2), 185–192. https://doi.org/10.1001/jamaoncol.2015.4333
Kesler, S. R., Watson, C. L., & Blayney, D. W. (2015). Brain network alterations and vulnerability to simulated neurodegeneration in breast cancer. Neurobiology of Aging, 36(8), 2429–2442. https://doi.org/10.1016/j.neurobiolaging.2015.04.015
Koppelmans, V., Breteler, M. M., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B. (2012a). Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Journal of Clinical Oncology, 30(10), 1080–1086. https://doi.org/10.1200/JCO.2011.37.0189
Koppelmans, V., de Ruiter, M. B., van der Lijn, F., Boogerd, W., Seynaeve, C., van der Lugt, A., . . . Schagen, S. B. (2012). Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Res Treat, 132(3), 1099-1106. https://doi.org/10.1007/s10549-011-1888-1
Krishnan, A., Williams, L. J., McIntosh, A. R., & Abdi, H. (2011). Partial Least Squares (PLS) methods for neuroimaging: A tutorial and review. NeuroImage, 56(2), 455–475. https://doi.org/10.1016/j.neuroimage.2010.07.034
Lee, P. E., Tierney, M. C., Wu, W., Pritchard, K. I., & Rochon, P. A. (2016). Endocrine treatment-associated cognitive impairment in breast cancer survivors: Evidence from published studies. Breast Cancer Research and Treatment, 158(3), 407–420. https://doi.org/10.1007/s10549-016-3906-9
Lepage, C., Smith, A. M., Moreau, J., Barlow-Krelina, E., Wallis, N., Collins, B., . . . Scherling, C. (2014). A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients. Springerplus, 3, 444. https://doi.org/10.1186/2193-1801-3-444
Linke, J. O., Stavish, C., Adleman, N. E., Sarlls, J., Towbin, K. E., Leibenluft, E., & Brotman, M. A. (2020). White matter microstructure in youth with and at risk for bipolar disorder. Bipolar Disorders, 22(2), 163–173. https://doi.org/10.1111/bdi.12885
McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study. Breast Cancer Research and Treatment, 123(3), 819–828. https://doi.org/10.1007/s10549-010-1088-4
McDonald, B. C., Conroy, S. K., Smith, D. J., West, J. D., & Saykin, A. J. (2013). Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study. Brain, Behavior, and Immunity, 30(Suppl), S117-125. https://doi.org/10.1016/j.bbi.2012.05.007
Menning, S., de Ruiter, M. B., Veltman, D. J., Boogerd, W., Oldenburg, H. S. A., Reneman, L., & Schagen, S. B. (2018). Changes in brain white matter integrity after systemic treatment for breast cancer: A prospective longitudinal study. Brain Imaging and Behavior, 12(2), 324–334. https://doi.org/10.1007/s11682-017-9695-x
Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., . . . Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc, 53(4), 695-699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
Pasternak, O., Westin, C. F., Dahlben, B., Bouix, S., & Kubicki, M. (2015). The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia. Schizophrenia Research, 161(1), 113–118. https://doi.org/10.1016/j.schres.2014.07.031
Pell, G. S., Briellmann, R. S., Chan, C. H., Pardoe, H., Abbott, D. F., & Jackson, G. D. (2008). Selection of the control group for VBM analysis: Influence of covariates, matching and sample size. NeuroImage, 41(4), 1324–1335. https://doi.org/10.1016/j.neuroimage.2008.02.050
Roland, J. L., Snyder, A. Z., Hacker, C. D., Mitra, A., Shimony, J. S., Limbrick, D. D., . . . Leuthardt, E. C. (2017). On the role of the corpus callosum in interhemispheric functional connectivity in humans. Proc Natl Acad Sci U S A, 114(50), 13278-13283. https://doi.org/10.1073/pnas.1707050114
Singh, N., Fletcher, P. T., Preston, J. S., King, R. D., Marron, J. S., Weiner, M. W., . . . Alzheimer's Disease Neuroimaging, I. (2014). Quantifying anatomical shape variations in neurological disorders. Med Image Anal, 18(3), 616-633. https://doi.org/10.1016/j.media.2014.01.001
Smith, S. M. (2002). Fast robust automated brain extraction. Human Brain Mapping, 17(3), 143–155. https://doi.org/10.1002/hbm.10062
Smith, S. M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T. E., Mackay, C. E., . . . Behrens, T. E. (2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage, 31(4), 1487-1505. https://doi.org/10.1016/j.neuroimage.2006.02.024
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E., Johansen-Berg, H., . . . Matthews, P. M. (2004). Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage, 23 Suppl 1, S208-219. https://doi.org/10.1016/j.neuroimage.2004.07.051
Stouten-Kemperman, M. M., de Ruiter, M. B., Koppelmans, V., Boogerd, W., Reneman, L., & Schagen, S. B. (2015). Neurotoxicity in breast cancer survivors >/=10 years post-treatment is dependent on treatment type. Brain Imaging and Behavior, 9(2), 275–284. https://doi.org/10.1007/s11682-014-9305-0
Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q. L., Hu, H., Chemerynsky, I., . . . Tannock, I. F. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol, 21(22), 4175-4183. https://doi.org/10.1200/JCO.2003.01.119
Turner, N., Biganzoli, L., & Di Leo, A. (2015). Continued value of adjuvant anthracyclines as treatment for early breast cancer. The Lancet Oncology, 16(7), e362-369. https://doi.org/10.1016/S1470-2045(15)00079-0
Underwood, E. A., Jerzak, K. J., Lebovic, G., Rochon, P. A., Elser, C., Pritchard, K. I., & Tierney, M. C. (2019). Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: A 1-year longitudinal study. Supportive Care in Cancer, 27(8), 3035–3043. https://doi.org/10.1007/s00520-018-4603-5
Underwood, E. A., Rochon, P. A., Moineddin, R., Lee, P. E., Wu, W., Pritchard, K. I., & Tierney, M. C. (2018). Cognitive sequelae of endocrine therapy in women treated for breast cancer: A meta-analysis. Breast Cancer Research and Treatment, 168(2), 299–310. https://doi.org/10.1007/s10549-017-4627-4
Van Dyk, K., Petersen, L., & Ganz, P. A. (2016). Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy. JAMA Oncology, 2(7), 964–965. https://doi.org/10.1001/jamaoncol.2016.0350
Vitaliano, P. P., Ustundag, O., & Borson, S. (2017). Objective and Subjective Cognitive Problems among Caregivers and Matched Non-caregivers. The Gerontologist, 57(4), 637–647. https://doi.org/10.1093/geront/gnv690
Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015). Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA: A Cancer Journal for Clinicians, 65(2), 123–138. https://doi.org/10.3322/caac.21258
Wilhelm, O., Hildebrandt, A., & Oberauer, K. (2013). What is working memory capacity, and how can we measure it? Frontiers in Psychology, 4, 433. https://doi.org/10.3389/fpsyg.2013.00433
Zhao, Q., Guo, Q., Liang, X., Chen, M., Zhou, Y., Ding, D., & Hong, Z. (2015). Auditory Verbal Learning Test is Superior to Rey-Osterrieth Complex Figure Memory for Predicting Mild Cognitive Impairment to Alzheimer’s Disease. Current Alzheimer Research, 12(6), 520–526. https://doi.org/10.2174/1567205012666150530202729
Zheng, Y., Luo, J., Bao, P., Cai, H., Hong, Z., Ding, D., . . . Dai, Q. (2014). Long-term cognitive function change among breast cancer survivors. Breast Cancer Res Treat, 146(3), 599-609. https://doi.org/10.1007/s10549-014-3044-1
This study was funded by the National Natural Science Foundation of China (Grant No. 81901821 and 82071879), the Science and Technology Plan of Shaanxi Province (Grant 2019SF-209), and the Fundamental Research Funds for the Central Universities (Grant Nos. JB211203 and XJS201207).
All procedures carried out in studies involving human participants were consistent with the ethical standards of institutions and/or national research councils, as well as with the 1964 Helsinki Declaration and its subsequent amendments or comparable ethical standards.
Consent to participant
Informed consent was obtained from all patients included in the study.
Consent to publish
All authors approved the version to be published in the study.
The author(s) declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zhang, H., Li, P., Liu, T. et al. Focal white matter microstructural alteration after anthracycline-based systemic treatment in long-term breast cancer survivors: a structural magnetic resonance imaging study. Brain Imaging and Behavior (2021). https://doi.org/10.1007/s11682-021-00551-3
- Breast cancer
- Cognitive impairment
- Anthracycline-based systemic treatment
- Tract-based spatial statistics
- Partial least squares regression